Nephrotoxicity of herbal products

Toxicology of Herbal Products

Volumn , Issue , 2017, Pages 307-344

  Baudoux, Thomas ^a   Nortier, Joëlle L ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Aristolochic acid; Nephrotoxicity; Proximal tubular injury; Renal toxic herbs

Indexed keywords

EID: 85032884889     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-43806-1_13     Document Type: Chapter

References (199)

1. Adams M, Berset C, Kessler M et al (2009) Medicinal herbs for the treatment of rheumatic disorders - a survey of European herbals from the 16th and 17th century. J Ethnopharmacol 121: 343-359
2. Adelekun TA, Ekwere TR, Akinsola A (1999) The pattern of acute toxic nephropathy in Ife, Nigeria. West Afr J Med 18: 60-63
3. Akyol AD, Yildirim Y, Toker E et al (2011) The use of complementary and alternative medicine among chronic renal failure patients. J Clin Nurs 20: 1035-1043
4. Ardalan MR, Khodaie L, Nasri H et al (2015) Herbs and hazards: risk of aristolochic acid nephropathy in Iran. Iran J Kidney Dis 9: 14-17
5. Arlt VM, Stiborova M, Schmeiser HH (2002) Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 17: 265-277
6. Aslam M, Davis SS, Healy MA (1979) Heavy metals in some Asian medicines and cosmetics. Public Health 93: 274-284
7. Balachandran P, Wei F, Lin RC et al (2005) Structure activity relationships of aristolochic acid analogues: toxicity in cultured renal epithelial cells. Kidney Int 67: 1797-1805
8. Barrett B, Kiefer D, Rabago D (1999) Assessing the risks and benefits of herbal medicine: an overview of scientific evidence. Altern Ther Health Med 5: 40-49
9. Baudoux TE, Pozdzik AA, Arlt VM et al (2012) Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy. Kidney Int 82: 1105-1113
10. Beger RD, Sun J, Schnackenberg LK (2010) Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol Appl Pharmacol 243: 154-166
11. Bertrand B (2009) L’herbier toxique. Codes secrets pour plantes utiles, Plume de carotte edn. Plume de carotte, Toulouse
12. Boudonck KJ, Rose DJ, Karoly ED et al (2009) Metabolomics for early detection of drug-induced kidney injury: review of the current status. Bioanalysis 1: 1645-1663
13. Catania JM, Parrish AR, Gandolfi AJ (2001) Toxicity of a sevoflurane degradation product incubated with rat liver and renal cortical slices. Drug Chem Toxicol 24: 347-357
14. Chan W, Lee KC, Liu N et al (2008) Liquid chromatography/mass spectrometry for metabonomics investigation of the biochemical effects induced by aristolochic acid in rats: the use of information-dependent acquisition for biomarker identification. Rapid Commun Mass Spectrom 22: 873-880
15. Chawla LS, Kimmel PL (2012) Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int 82: 516-524
16. Chen M, Su M, Zhao L et al (2006) Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. J Proteome Res 5: 995-1002
17. Chen CH, Dickman KG, Moriya M et al (2012) Aristolochic acid-associated urothelial cancer in Taiwan. Proceedings of the National Academy of Sciences of the United States of America
18. Coghlan ML, Haile J, Houston J et al (2012) Deep sequencing of plant and animal DNA contained within traditional Chinese medicines reveals legality issues and health safety concerns. PLoS Genet 8:e1002657
19. Colson CRD, De Broe ME (2005) Kidney injury from alternative medicines. Adv Chron Kid Dis 12: 261-275
20. Committee on the Framework for Evaluating the Safety of the Dietary Supplements, National Research Council (2004) Dietary supplements: a framework for evaluating safety. Washington, DC
21. Cosyns JP, Jadoul M, Squifflet JP et al (1994) Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int 45: 1680-1688
22. Cosyns JP, Jadoul M, Squifflet JP et al (1999) Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 33: 1011-1017
23. Cosyns JP, Dehoux JP, Guiot Y et al (2001) Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int 59: 2164-2173
24. Couceiro M, Afreen F, Zobayed S et al (2006) Variation in concentrations of major bioactive compounds of St. John’s wort: effects of harvesting time, temperature and germplasm. Plant Sci 170: 128-134
25. Dan H, Peng RX, Ao Y et al (2008) Segment-specific proximal tubule injury in tripterygium glycosides intoxicated rats. J Biochem Mol Toxicol 22: 422-428
26. De Broe ME (2012) Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy. Kidney Int 81: 513-515
27. De Broe ME, Porter George A (2008) Clinical nephrotoxins: renal injury from drugs and chemicals. Kluwer Academic Publishers, Dordrecht, The Netherlands
28. De Smet PA (2007) Clinical risk management of herb-drug interactions. Br J Clin Pharmacol 63: 258-267
29. Debelle FD, Nortier JL, De Prez EG et al (2002) Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol 13: 431-436
30. Debelle FD, Vanherweghem JL, Nortier JL (2008) Aristolochic acid nephropathy: a worldwide problem. Kidney Int 74: 158-169
31. Depierreux M, Van Damme B, Vanden Houte K et al (1994) Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 24: 172-180
32. Devarajan P (2008) Proteomics for the investigation of acute kidney injury. Contrib Nephrol 160: 1-16
33. Dickman KG, Sweet DH, Bonala R et al (2011) Physiological and molecular characterization of aristolochic acid transport by the kidney. J Pharmacol Exp Ther 338: 588-597
34. Djukanovic L, Radovic M, Bakovic J et al (2002) Epidemiology of end-stage renal disease and current status of hemodialysis in Yugoslavia. Int J Artif Organs 25: 852-859
35. Dunn JP, Krige JE, Wood R et al (1991) Colonic complications after toxic tribal enemas. Br J Surg 78: 545-548
36. Ebbels TM, Keun HC, Beckonert OP et al (2007) Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. J Proteome Res 6: 4407-4422
37. El Dirdiri NI, Barakat SE, Adam SE (1987) The combined toxicity of Aristolochia bracteata and Cadaba rotundifolia to goats. Vet Hum Toxicol 29: 133-137
38. European Food Safety Authority (2009) Guidance on safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements. EFSA J 7: 1249-1268
39. Fadrowski JJ, Navas-Acien A, Tellez-Plaza M et al (2010) Blood lead level and kidney function in US adolescents: the third National Health and Nutrition Examination Survey. Arch Intern Med 170: 75-82
40. Ferraro PM, Costanzi S, Naticchia A et al (2010) Low level exposure to cadmium increases the risk of chronic kidney disease: analysis of the NHANES 1999-2006. BMC Public Health 10: 304
41. Gabardi S, Munz K, Ulbricht C (2007) A review of dietary supplement-induced renal dysfunction. Clin J Am Soc Nephrol 2: 757-765
42. Gandolfi AJ, Brendel K (1990) In vitro systems for nephrotoxicity studies. Toxicol In Vitro 4: 337-345
43. Garvey GJ, Hahn G, Lee RV et al (2001) Heavy metal hazards of Asian traditional remedies. Int J Environ Health Res 11: 63-71
44. Gibbs A (2005) Comparison of the specificity and sensitivity of traditional methods for assessment of nephrotoxicity in the rat with metabonomic and proteomic methodologies. J Appl Toxicol 25: 277-295
45. Gokmen MR, Cosyns JP, Arlt VM et al (2013) The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review. Ann Intern Med 158: 469-477
46. Grollman AP (2013) Aristolochic acid nephropathy: harbinger of a global iatrogenic disease. Environ Mol Mutagen 54: 1-7
47. Grubbs V, Plantinga LC, Tuot DS et al (2013) Americans’ use of dietary supplements that are potentially harmful in CKD. Am J Kidney Dis 61: 739-747
48. Guh JY, Chen HC, Tsai JF et al (2007) Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan. Am J Kidney Dis 49: 626-633
49. Harmon RC, Duffy SP, Terneus MV et al (2009) Characterization of a novel model for investigation of radiocontrast nephrotoxicity. Nephrol Dial Transplant 24: 763-768
50. Hashimoto K, Higuchi M, Makino B et al (1999) Quantitative analysis of aristolochic acids, toxic compounds, contained in some medicinal plants. J Ethnopharmacol 64: 185-189
51. He CC, Dai YQ, Hui RR et al (2011) NMR-based metabonomic approach on the toxicological effects of a Cimicifuga triterpenoid. J Appl Toxicol 32: 88-97
52. Heinrich M, Chan J, Wanke S et al (2009) Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2 - a global assessment based on bibliographic sources. J Ethnopharmacol 125: 108-144
53. Hess S, De Geest S, Halter K et al (2009) Prevalence and correlates of selected alternative and complementary medicine in adult renal transplant patients. Clin Transpl 23: 56-62
54. Hsieh SC, Lin IH, Tseng WL et al (2008) Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003. Chin Med 3: 13
55. Ioset JR, Raoelison GE, Hostettmann K (2003) Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens. Food Chem Toxicol 41: 29-36
56. Isnard Bagnis C, Deray G, Baumelou A et al (2004) Herbs and the kidney. Am J Kidney Dis 44: 1-11
57. Ivic M (1969) Etiology of endemic nephropathy. Lijec Vjesn 91: 1273-1281
58. Jelakovic B, Karanovic S, Vukovic-Lela I et al (2012) Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int 81: 559-567
59. Jordan SA, Cunningham DG, Marles RJ (2010) Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment. Toxicol Appl Pharmacol 243: 198-216
60. Krumbiegel G, Hallensleben J, Mennicke WH et al (1987) Studies on the metabolism of aristolochic acids I and II. Xenobiotica 17: 981-991
61. Ladda MA, Goralski KB (2016) The effects of CKD on cytochrome P450-mediated drug metabolism. Adv Chronic Kidney Dis 23: 67-75
62. Lai MN, Lai JN, Chen PC et al (2009) Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid. Nephrology (Carlton) 14: 227-234
63. Laïs E (2003) Le grand livre des plantes magiques. Jardin de sorcières, Rustica edn. Rustica, Paris
64. Lao YM, Jiang JG, Yan L (2009) Application of metabonomic analytical techniques in the modernization and toxicology research of traditional Chinese medicine. Br J Pharmacol 157: 1128-1141
65. Lemy A, Wissing KM, Rorive S et al (2008) Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up. Am J Kidney Dis 51: 471-477
66. Lin S, Chan W, Li J et al (2010) Liquid chromatography/mass spectrometry for investigating the biochemical effects induced by aristolochic acid in rats: the plasma metabolome. Rapid Commun Mass Spectrom 24: 1312-1318
67. Luyckx VA (2012) Nephrotoxicity of alternative medicine practice. Adv Chronic Kidney Dis 19: 129-141
68. Luyckx VA, Naicker S (2008) Acute kidney injury associated with the use of traditional medicines. Nat Clin Pract Nephrol 4: 664-671
69. Luyckx VA, Steenkamp V, Stewart MJ (2005) Acute renal failure associated with the use of traditional folk remedies in South Africa. Ren Fail 27: 35-43
70. Lv H, Liu L, Palacios G et al (2011) Metabolomic analysis characterizes tissue specific indomethacin-induced metabolic perturbations of rats. Analyst 136: 2260-2269
71. Ma C, Bi K, Su D et al (2010) Serum and kidney metabolic changes of rat nephrotoxicity induced by morning glory seed. Food Chem Toxicol 48: 2988-2993
72. Mai I, Stormer E, Bauer S et al (2003) Impact of St. John’s wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients. Nephrol Dial Transplant 18: 819-822
73. Marcus DM, Grollman AP (2002) Botanical medicines - the need for new regulations. N Engl J Med 347: 2073-2076
74. Martins AM, Toyama MH, Havt A et al (2002) Determination of Crotalus durissus cascavella venom components that induce renal toxicity in isolated rat kidneys. Toxicon 40: 1165-1171
75. Minigh JL, Valentovic MA (2003) Characterization of myoglobin toxicity in renal cortical slices from Fischer 344 rats. Toxicology 184: 113-123
76. Mosihuzzaman M, Choudhary I, M (2008) Protocols on safety, efficacy, standardization and documentation of herbal medicine. Pure Appl Chem 80: 2195-2230
77. Navas-Acien A, Tellez-Plaza M, Guallar E et al (2009) Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol 170: 1156-1164
78. Newmaster SG, Grguric M, Shanmughanandhan D et al (2013) DNA barcoding detects contamination and substitution in North American herbal products. BMC Med 11: 222
79. Nortier JL, Martinez MC, Schmeiser HH et al (2000) Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342: 1686-1692
80. Nortier J, Pozdzik A, Roumeguere T et al (2015) Néphropathie aux acides aristolochiques (“néphropathie aux herbes chinoises”). Nephrol Ther 11: 574-588
81. Nowack R, Balle C, Birnkammer F et al (2009) Complementary and alternative medications consumed by renal patients in southern Germany. J Ren Nutr 19: 211-219
82. Nwoko CO, Mgbeahuruike L (2011) Heavy metal contamination of ready-to-use herbal remedies in South Eastern Nigeria. Pak J Nutr 10: 959-964
83. Obi E, Akunyili DN, Ekpo B et al (2006) Heavy metal hazards of Nigerian herbal remedies. Sci Total Environ 369: 35-41
84. Olowu WA, Niang A, Osafo C et al (2016) Outcomes of acute kidney injury in children and adults in sub-Saharan Africa: a systematic review. Lancet Glob Health 4:e242-e250
85. Pavlovi NM (2013) Balkan endemic nephropathy - current status and future perspectives. Clin Kidney J 6: 257-265
86. Perazella MA (2009) Renal vulnerability to drug toxicity. Clin J Am Soc Nephrol 4: 1275-1283
87. Ponce D, Dias DB, Nascimento GR et al (2016) Long-term outcome of severe acute kidney injury survivors followed by nephrologists in a developing country. Nephrology (Carlton) 21: 327-334
88. Pozdzik AA, Salmon IJ, Debelle FD et al (2008a) Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int 73: 595-607
89. Pozdzik AA, Salmon IJ, Husson CP et al (2008b) Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrol Dial Transplant 23: 2480-2491
90. Rouse RL, Zhang J, Stewart SR et al (2011) Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats. Kidney Int 79: 1186-1197
91. Sabath E, Robles-Osorio ML (2012) Renal health and the environment: heavy metal nephrotoxicity. Nefrologia 32: 279-286
92. Saper RB, Kales SN, Paquin J et al (2004) Heavy metal content of Ayurvedic herbal medicine products. JAMA 292: 2868-2873
93. Schilter B, Andersson C, Anton R et al (2003) Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplements. Food Chem Toxicol 41: 1625-1649
94. Schmeiser HH, Nortier JL, Singh R et al (2014) Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy. Int J Cancer 135: 502-507
95. Shanley PF, Brezis M, Spokes K et al (1986) Differential responsiveness of proximal tubule segments to metabolic inhibitors in the isolated perfused rat kidney. Am J Kidney Dis 7: 76-83
96. Sieber M, Wagner S, Rached E et al (2009) Metabonomic study of ochratoxin a toxicity in rats after repeated administration: phenotypic anchoring enhances the ability for biomarker discovery. Chem Res Toxicol 22: 1221-1231
97. Siew ED, Peterson JF, Eden SK et al (2012) Outpatient nephrology referral rates after acute kidney injury. J Am Soc Nephrol 23: 305-312
98. Stanifer JW, Jing B, Tolan S et al (2014) The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health 2:e174-e181
99. Taber SS, Pasko DA (2008) The epidemiology of drug-induced disorders: the kidney. Expert Opin Drug Saf 7: 679-690
100. Taft DR (2004) The isolated perfused rat kidney model: a useful tool for drug discovery and development. Curr Drug Discov Technol 1: 97-111
101. Tatu CA, Orem WH, Finkelman RB et al (1998) The etiology of Balkan endemic nephropathy: still more questions than answers. Environ Health Perspect 106: 689-700
102. Tyagi R, Rana P, Gupta M et al (2013) Differential biochemical response of rat kidney towards low and high doses of NiCl2 as revealed by NMR spectroscopy. J Appl Toxicol 33: 134-141
103. Vanhaelen M, Vanhaelen-Fastre R, But P et al (1994) Identification of aristolochic acid in Chinese herbs. Lancet 343: 174
104. Vanherweghem JL (1997) Aristolochia sp and chronic interstitial nephropathies in Indians. Lancet 349: 1399
105. Vanherweghem LJ (1998) Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med 4: 9-13
106. Vanherweghem JL, Depierreux M, Tielemans C et al (1993) Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341: 387-391
107. Vanherweghem JL, Abramowicz D, Tielemans C et al (1996) Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy. Am J Kidney Dis 27: 209-215
108. Vickers AE, Fisher RL (2004) Organ slices for the evaluation of human drug toxicity. Chem Biol Interact 150: 87-96
109. Vickers AE, Rose K, Fisher R et al (2004) Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology. Toxicol Pathol 32: 577-590
110. Wei L, Liao P, Wu H et al (2008) Toxicological effects of cinnabar in rats by NMR-based metabolic profiling of urine and serum. Toxicol Appl Pharmacol 227: 417-429
111. Wei L, Liao P, Wu H et al (2009) Metabolic profiling studies on the toxicological effects of realgar in rats by (1)H NMR spectroscopy. Toxicol Appl Pharmacol 234: 314-325
112. WHO traditional medicine strategy 2014-2023 (2013) www.who.int/medicines/publications/traditional/trm_strategy14_23/en/(last access December 14, 2016)
113. Williamson EM, Chan K, Xu Q et al (2015) Evaluating the safety of herbal medicines: integrated toxicological approaches. Science 347: S47-S49
114. Wojcikowski K, Wohlmuth H, Johnson DW et al (2009) An in vitro investigation of herbs traditionally used for kidney and urinary system disorders: potential therapeutic and toxic effects. Nephrology (Carlton) 14: 70-79
115. World Health Organization (2004) WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. See http://apps.who.int/medicinedocs/en/d/Js7148e/
116. World Health Organization (2007) WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. See http://apps.who.int/medicinedocs/fr/m/abstract/Js14878e/
117. Wu KM, Farrelly JG, Upton R et al (2007) Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development. Phytomedicine 14: 273-279
118. Xia S, Liu H, Zhu H et al (2009) NMR-based metabonomic study on rat’s urinary metabolic response to dosage of triptolide. Chin J Chem 27: 751-758
119. Yamani A, Bunel V, Antoine MH et al (2015) Substitution between Aristolochia and Bryonia genus in North-Eastern Morocco: toxicological implications. J Ethnopharmacol 166: 250-260
120. Yang MH, Chen KK, Yen CC et al (2002) Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology 59: 681-687
121. Yu CC, Lin JL, Lin-Tan DT (2004) Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J Am Soc Nephrol 15: 1016-1022
122. Yu FY, Wu TS, Chen TW et al (2011) Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1/2 activation in human cells. Toxicol In Vitro 25: 810-816
123. Yuan SY, Yang CR, Cheng CL et al (2011) Comparative nephrotoxicity of aristolochic acid and tetrandrine in vitro and in vivo. Int J Toxicol 30: 35-46
124. Zhang X, Wu H, Liao P et al (2006) NMR-based metabonomic study on the subacute toxicity of aristolochic acid in rats. Food Chem Toxicol 44: 1006-1014
125. Zhao Z, Yuen JP, Wu J et al (2006) A systematic study on confused species of Chinese materia medica in the Hong Kong market. Ann Acad Med Singap 35: 764-769
126. Adesunloye BA (2003) Acute renal failure due to the herbal remedy CKLS. Am J Med 115: 506-507
127. Averbukh Z, Modai D, Leonov Y et al (1989) Rhabdomyolysis and acute renal failure induced by paraphenylenediamine. Hum Toxicol 8: 345-348
128. Bandara V, Weinstein SA, White J et al (2010) A review of the natural history, toxinology, diagnosis and clinical management of Nerium oleander (common oleander) and Thevetia peruviana (yellow oleander) poisoning. Toxicon 56: 273-281
129. Benjamin SP, Fernando ME, Jayanth JJ et al (2006) Cleistanthus collinus poisoning. J Assoc Physicians India 54: 742-744
130. Boubaker K, Ounissi M, Brahmi N et al (2013) Acute renal failure by ingestion of Euphorbia paralias. Saudi J Kidney Dis Transpl 24: 571-575
131. Bourquia A, Jabrane AJ, Ramdani B et al (1988) Systemic toxicity of paraphenylenediamine. 4 cases. Presse Med 17: 1798-1800
132. Brncic N, Viskovic I, Peric R et al (2001) Accidental plant poisoning with Colchicum autumnale: report of two cases. Croat Med J 42: 673-675
133. Brvar M, Ploj T, Kozelj G et al (2004) Case report: fatal poisoning with Colchicum autumnale. Crit Care 8: R56-R59
134. Bunawan NC, Rastegar A, White KP et al (2014) Djenkolism: case report and literature review. Int Med Case Rep J 7: 79-84
135. Chen CL, Fang HC, Chou KJ et al (2001) Acute oxalate nephropathy after ingestion of star fruit. Am J Kidney Dis 37: 418-422
136. Chou WC, Wu CC, Yang PC et al (1995) Hypovolemic shock and mortality after ingestion of Tripterygium wilfordii hook F.: a case report. Int J Cardiol 49: 173-177
137. Chrispal A (2012) Cleistanthus collinus poisoning. J Emerg Trauma Shock 5: 160-166
138. Conz PA, La Greca G, Benedetti P et al (1998) Fucus vesiculosus: a nephrotoxic alga? Nephrol Dial Transplant 13: 526-527
139. Daniele C, Dahamna S, Firuzi O et al (2005) Atractylis gummifera L. poisoning: an ethnopharmacological review. J Ethnopharmacol 97: 175-181
140. Das S, Hamide A, Mohanty MK et al (2014) Fatal Cleistanthus collinus toxicity: a case report and review of literature. J Forensic Sci 59: 1441-1447
141. Diamond JR, Pallone TL (1994) Acute interstitial nephritis following use of tung shueh pills. Am J Kidney Dis 24: 219-221
142. Djibo A, Bouzou SB (2000) Acute intoxication with “sobi-lobi” (Datura). Four cases in Niger. Bull Soc Pathol Exot 93: 294-297
143. Ernst E (2002) St. John’s wort supplements endanger the success of organ transplantation. Arch Surg 137: 316-319
144. Fang HC, Lee PT, Lu PJ et al (2008) Mechanisms of star fruit-induced acute renal failure. Food Chem Toxicol 46: 1744-1752
145. Haller CA, Benowitz NL (2000) Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 343: 1833-1838
146. Hilepo JN, Bellucci AG, Mossey RT (1997) Acute renal failure caused by “cat’s claw” herbal remedy in a patient with systemic lupus erythematosus. Nephron 77: 361
147. Horoz M, Gok E, Genctoy G et al (2008) Crataegus orientalis associated multiorgan hypersensitivity reaction and acute renal failure. Intern Med 47: 2039-2042
148. Hsu HY, Lin CC, Chen JY et al (1998) Toxic effects of Erycibe obtusifolia, a Chinese medicinal herb, in mice. J Ethnopharmacol 62: 101-105
149. Huang HH, Yen DH, Wu ML et al (2006) Acute erycibe henryi prain (“Ting Kung Teng”) poisoning. Clin Toxicol (Phila) 44: 71-75
150. Huang GZ, Li L, Liu L (2009) Pathological study on autopsy died of tripterygium intoxication -report of 4 cases. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi Chin J Integr Tradit West Med/Zhongguo Zhong Xi Yi Jie He Xue Hui Zhongguo Zhong Yi Yan Jiu Yuan Zhu Ban 29: 165-168
151. Jha V (2010) Herbal medicines and chronic kidney disease. Nephrology (Carlton) 15(Suppl 2): 10-17
152. Jha V, Parameswaran S (2013) Community-acquired acute kidney injury in tropical countries. Nat Rev Nephrol 9: 278-290
153. Kang K-S, Heo ST (2015) A case of life-threatening acute kidney injury with toxic encephalopathy caused by Dioscorea quinqueloba. Yonsei Med J 56: 304-306
154. Kim CS, Kim SM, Choi JS et al (2012) Dioscorea quinqueloba induces acute kidney injury. Clin Toxicol (Phila) 50: 80
155. Kim HY, Kim SS, Bae SH et al (2014) Acute interstitial nephritis induced by Dioscorea quinqueloba. BMC Nephrol 15: 143
156. Klintschar M, Beham-Schmidt C, Radner H et al (1999) Colchicine poisoning by accidental ingestion of meadow saffron (Colchicum autumnale): pathological and medicolegal aspects. Forensic Sci Int 106: 191-200
157. Kwan TH, Tong MK, Leung KT et al (2006) Acute renal failure associated with prolonged intake of slimming pills containing anthraquinones. Hong Kong Med J 12: 394-397
158. Kwan LP, Mok MM, Ma MK et al (2014) Acute drug toxicity related to drinking herbal tea in a kidney transplant recipient. Ren Fail 36: 309-312
159. Lee JJ, Chen HC (2006) Flavonoid-induced acute nephropathy by Cupressus funebris Endl (mourning cypress). Am J Kidney Dis 48:e81-e85
160. Li FK, Lai CK, Poon WT et al (2004) Aggravation of non-steroidal anti-inflammatory drug-induced hepatitis and acute renal failure by slimming drug containing anthraquinones. Nephrol Dial Transplant 19: 1916-1917
161. Light TD, Light JA (2003) Acute renal transplant rejection possibly related to herbal medications. Am J Transplant 3: 1608-1609
162. Lin CC, Chen JC (2002) Medicinal herb Erycibe henri Prain (“Ting Kung Teng”) resulting in acute cholinergic syndrome. J Toxicol Clin Toxicol 40: 185-187
163. Lin JL, Ho YS (1994) Flavonoid-induced acute nephropathy. Am J Kidney Dis 23: 433-440
164. Logan JL, Ahmed J (2003) Critical hypokalemic renal tubular acidosis due to Sjogren’s syndrome: association with the purported immune stimulant echinacea. Clin Rheumatol 22: 158-159
165. Luyckx VA, Ballantine R, Claeys M et al (2002) Herbal remedy-associated acute renal failure secondary to Cape aloes. Am J Kidney Dis 39: E13
166. Mueller BA, Scott MK, Sowinski KM et al (2000) Noni juice (Morinda citrifolia): hidden potential for hyperkalemia? Am J Kidney Dis 35: 310-312
167. Mullins RJ, Heddle R (2002) Adverse reactions associated with echinacea: the Australian experience. Ann Allergy Asthma Immunol 88: 42-51
168. Neto MM, Silva GE, Costa RS et al (2009) Star fruit: simultaneous neurotoxic and nephrotoxic effects in people with previously normal renal function. NDT Plus 2: 485-488
169. Popat A, Shear NH, Malkiewicz I et al (2001) The toxicity of Callilepis laureola, a South African traditional herbal medicine. Clin Biochem 34: 229-236
170. Powell T, Hsu FF, Turk J et al (1998) Ma-huang strikes again: ephedrine nephrolithiasis. Am J Kidney Dis 32: 153-159
171. Prakash J (1999) Acute renal failure in epidemic dropsy. Ren Fail 21: 707-711
172. Prakash S, Hernandez GT, Dujaili I et al (2009) Lead poisoning from an Ayurvedic herbal medicine in a patient with chronic kidney disease. Nat Rev Nephrol 5: 297-300
173. Rhidian R (2011) Running a risk? Sport supplement toxicity with ephedrine in an amateur marathon runner, with subsequent rhabdomyolysis. BMJ Case Rep 2011, doi: 10.1136/bcr.11.2011.5093
174. Sandler B, Aronson P (1993) Yohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome. Urology 41: 343-345
175. Schwarz A (1993) Beethoven’s renal disease based on his autopsy: a case of papillary necrosis. Am J Kidney Dis 21: 643-652
176. Seedat YK (1993) Acute renal failure in the black population of South Africa. Int J Artif Organs 16: 801-802
177. Seedat YK, Hitchcock PJ (1971) Acute renal failure from Callilepsis laureola. S Afr Med J 45: 832-833
178. Segasothy M, Samad S (1991) Illicit herbal preparation containing phenylbutazone causing analgesic nephropathy. Nephron 59: 166-167
179. Segasothy M, Swaminathan M, Kong NC et al (1995) Djenkol bean poisoning (djenkolism): an unusual cause of acute renal failure. Am J Kidney Dis 25: 63-66
180. Sharma BD, Malhotra S, Bhatia V et al (1999) Epidemic dropsy in India. Postgrad Med J 75: 657-661
181. Shemesh IY, Mishal Y, Baruchin AM et al (1995) Rhabdomyolysis in paraphenylenediamine intoxication. Vet Hum Toxicol 37: 244-245
182. Sir Hashim M, Hamza YO, Yahia B et al (1992) Poisoning from henna dye and para-phenylenediamine mixtures in children in Khartoum. Ann Trop Paediatr 12: 3-6
183. Smith AY, Feddersen RM, Gardner KD Jr et al (1994) Cystic renal cell carcinoma and acquired renal cystic disease associated with consumption of chaparral tea: a case report. J Urol 152: 2089-2091
184. Snow A, Halpenny D, McNeill G et al (2012) Life-threatening rupture of a renal angiomyolipoma in a patient taking over-the-counter horse chestnut seed extract. J Emerg Med 43:e401-e403
185. Stahl CE, Borlongan CV, Szerlip M et al (2006) No pain, no gain - exercise-induced rhabdomyolysis associated with the performance enhancer herbal supplement ephedra. Med Sci Monit 12: Cs81-Cs84
186. Steenkamp V, Stewart MJ (2005) Nephrotoxicity associated with exposure to plant toxins, with particular reference to Africa. Ther Drug Monit 27: 270-277
187. Stewart MJ, Steenkamp V (2000) The biochemistry and toxicity of atractyloside: a review. Ther Drug Monit 22: 641-649
188. Talasaz AH, Abbasi MR, Abkhiz S et al (2010) Tribulus terrestris-induced severe nephrotoxicity in a young healthy male. Nephrol Dial Transplant 25: 3792-3793
189. Terris MK, Issa MM, Tacker JR (2001) Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 57: 26-29
190. Vachvanichsanong P, Lebel L (1997) Djenkol beans as a cause of hematuria in children. Nephron 76: 39-42
191. Vanderperren B, Rizzo M, Angenot L et al (2005) Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 39: 1353-1357
192. Vanholder R, De Smet R, Lesaffer G (1999) p-cresol: a toxin revealing many neglected but relevant aspects of uraemic toxicity. Nephrol Dial Transplant 14: 2813-2815
193. Watson AR, Coovadia HM, Bhoola KD (1979) The clinical syndrome of Impila (Callilepis laureola) poisoning in children. S Afr Med J 55: 290-292
194. Weisbord SD, Soule JB, Kimmel PL (1997) Poison on line - acute renal failure caused by oil of wormwood purchased through the Internet. N Engl J Med 337: 825-827
195. Wong JS, Ong TA, Chua HH et al (2007) Acute anuric renal failure following jering bean ingestion. Asian J Surg 30: 80-81
196. Wood R, Mills PB, Knobel GJ et al (1990) Acute dichromate poisoning after use of traditional purgatives. A report of 7 cases. S Afr Med J 77: 640-642
197. Wu MS, Hong JJ, Lin JL et al (1996) Multiple tubular dysfunction induced by mixed Chinese herbal medicines containing cadmium. Nephrol Dial Transplant 11: 867-870
198. Yang L, Su T, Li XM et al (2011) Aristolochic acid nephropathy: variation in presentation and prognosis. Nephrol Dial Transplant 27: 292-298
199. Zhang WX, Zhang ZM, Zhang ZQ et al (2014) Andrographolide induced acute kidney injury: analysis of 26 cases reported in Chinese literature. Nephrology (Carlton) 19: 21-26